Morphologic and molecular evidence of a dual species ehrlichial infection in a dog presenting with inflammatory central nervous system disease.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 9773417)

Published in J Vet Intern Med on December 04, 1998

Authors

J H Meinkoth1, S A Ewing, R L Cowell, J E Dawson, C K Warner, J S Mathew, M Bowles, A E Thiessen, R J Panciera, C Fox

Author Affiliations

1: Department of Anatomy, Pathology and Pharamacology, Oklahoma State University, Stillwater 74078, USA. jhm@okway.okstate.edu

Articles by these authors

Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J Clin Microbiol (1991) 8.36

Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ (2008) 6.23

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med (1995) 5.69

Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc Natl Acad Sci U S A (1996) 5.34

Macrophages as a source of HIV during opportunistic infections. Science (1997) 3.92

Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction. J Clin Microbiol (1992) 3.81

Serologic diagnosis of human ehrlichiosis using two Ehrlichia canis isolates. J Infect Dis (1991) 3.68

Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med (1994) 3.62

Pupillary signs in diabetic autonomic neuropathy. Br Med J (1978) 2.79

Observations on septicemia of cattle caused by a haemophilus-like organism. Pathol Vet (1968) 2.76

Experimental transmission of Ehrlichia chaffeensis (Rickettsiales: Ehrlichieae) among white-tailed deer by Amblyomma americanum (Acari: Ixodidae). J Med Entomol (1995) 2.69

Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988. JAMA (1990) 2.60

Epidemiologic and historical relationships among 87 rabies virus isolates as determined by limited sequence analysis. J Infect Dis (1992) 2.60

Analyses of Ehrlichia canis and a canine granulocytic Ehrlichia infection. J Clin Microbiol (1992) 2.57

Diagnosis of equine monocytic ehrlichiosis (Potomac horse fever) by indirect immunofluorescence. J Am Vet Med Assoc (1986) 2.49

Lord Bradley's review of people with mental health or learning disabilities in the criminal justice system in England: All not equal in the eyes of the law? Int J Prison Health (2009) 2.33

Western immunoblot analysis of Ehrlichia chaffeensis, E. canis, or E. ewingii infections in dogs and humans. J Clin Microbiol (1994) 2.32

Ehrlichia ewingii sp. nov., the etiologic agent of canine granulocytic ehrlichiosis. Int J Syst Bacteriol (1992) 2.31

Polymerase chain reaction evidence of Ehrlichia chaffeensis, an etiologic agent of human ehrlichiosis, in dogs from southeast Virginia. Am J Vet Res (1996) 2.17

First European case of ehrlichiosis. Lancet (1991) 2.02

Human ehrlichiosis: hematopathology and immunohistologic detection of Ehrlichia chaffeensis. Hum Pathol (1993) 1.99

Canine ehrlichiosis. Adv Vet Sci Comp Med (1969) 1.94

Drosophila melanogaster ma-l mutants are defective in the sulfuration of desulfo Mo hydroxylases. J Biol Chem (1982) 1.91

Theatre air sampling--ignorance is bliss! J Hosp Infect (1995) 1.91

Identification of coagulase-negative staphylococci with the API staph system. J Clin Microbiol (1982) 1.85

Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis (1989) 1.84

Susceptibility of dogs to infection with Ehrlichia chaffeensis, causative agent of human ehrlichiosis. Am J Vet Res (1992) 1.81

Human granulocytic ehrlichiosis in Massachusetts. Ann Intern Med (1995) 1.81

Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24. J Bacteriol (1992) 1.81

Development of Anaplasma marginale in male Dermacentor andersoni transferred from parasitemic to susceptible cattle. Am J Vet Res (1992) 1.76

Community-based asthma care: trial of a "credit card" asthma self-management plan. Eur Respir J (1994) 1.76

Experimental transmission of a granulocytic form of the tribe Ehrlichieae by Dermacentor variabilis and Amblyomma americanum to dogs. Am J Vet Res (1990) 1.75

Ehrlichia-like 16S rDNA sequence from wild white-tailed deer (Odocoileus virginianus). J Parasitol (1996) 1.74

Ehrlichiosis in a golf-oriented retirement community. N Engl J Med (1995) 1.71

A molecular and serologic survey of Ehrlichia canis, E. chaffeensis, and E. ewingii in dogs and ticks from Oklahoma. Vet Parasitol (1998) 1.71

Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel. Emerg Infect Dis (2000) 1.68

Isolation of Ehrlichia chaffeensis from wild white-tailed deer (Odocoileus virginianus) confirms their role as natural reservoir hosts. J Clin Microbiol (1997) 1.67

A new strain of Ehrlichia canis. J Am Vet Med Assoc (1971) 1.58

Daily energy expenditure in Mexican and USA Pima indians: low physical activity as a possible cause of obesity. Int J Obes Relat Metab Disord (2000) 1.55

An outbreak of ehrlichiosis in members of an Army Reserve unit exposed to ticks. J Infect Dis (1989) 1.55

2,4-D metabolism: enzymatic conversion of chloromaleylacetic acid to succinic acid. J Agric Food Chem (1972) 1.48

Duration of tick attachment required for transmission of granulocytic ehrlichiosis. J Infect Dis (1998) 1.47

A single tissue culture system for the propagation of the agents of the human ehrlichioses. Am J Trop Med Hyg (1998) 1.46

Serum neutralization of cytotoxin from Pasteurella haemolytica, serotype 1 and resistance to experimental bovine pneumonic pasteurellosis. Vet Immunol Immunopathol (1985) 1.44

Standard effective doses for proliferative tumours. Phys Med Biol (1999) 1.39

Nonregenerative anaemia associated with administration of recombinant human erythropoietin to a Thoroughbred racehorse. Equine Vet J (1997) 1.39

Distribution of Pasteurella haemolytica and Pasteurella multocida in the bovine lung following vaccination and challenge exposure as an indicator of lung resistance. Am J Vet Res (1982) 1.39

Effect of vaccination with live or killed Pasteurella haemolytica on resistance to experimental bovine pneumonic pasteurellosis. Am J Vet Res (1985) 1.37

The natural history of Anaplasma marginale. Vet Parasitol (2009) 1.34

The first isolation, in vitro propagation, and genetic characterization of Ehrlichia canis in Israel. Vet Parasitol (1996) 1.33

Brief report: fatal seronegative ehrlichiosis in a patient with HIV infection. N Engl J Med (1993) 1.32

Gonococcal infection within Scotland: antigenic heterogeneity and antibiotic susceptibility of infecting strains. Eur J Epidemiol (1990) 1.31

Malignancy and mortality in a population-based cohort of patients with coeliac disease or "gluten sensitivity". World J Gastroenterol (2007) 1.30

Site-specific geographic association between Amblyomma americanum (Acari: Ixodidae) infestations and Ehrlichia chaffeensis-reactive (Rickettsiales: Ehrlichieae) antibodies in white-tailed deer. J Med Entomol (1996) 1.30

Natural history of Ehrlichia chaffeensis (Rickettsiales: Ehrlichieae) in the piedmont physiographic province of Georgia. J Parasitol (1997) 1.29

Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: a comparison with untreated patients and normal age-matched controls. Mov Disord (2001) 1.29

Development of Anaplasma marginale in salivary glands of male Dermacentor andersoni. Am J Vet Res (1993) 1.29

Infectivity of three Anaplasma marginale isolates for Dermacentor andersoni. Am J Vet Res (1987) 1.27

Transmission of Anaplasma marginale Theiler by Dermacentor andersoni Stiles and Dermacentor variabilis (Say). Am J Vet Res (1981) 1.26

Relationships of patient satisfaction with experience of system performance and health status. J Ambul Care Manage (1995) 1.25

The interface between research and the diagnosis of an emerging tick-borne disease, human ehrlichiosis due to Ehrlichia chaffeensis. Arch Intern Med (1996) 1.25

Pharmacokinetics of oral ciprofloxacin, 100 mg single dose, in volunteers and elderly patients. J Antimicrob Chemother (1986) 1.24

Natural coinfection of a white-tailed deer (Odocoileus virginianus) population with three Ehrlichia spp. J Parasitol (1998) 1.24

Persistence of Anaplasma marginale (Rickettsiales: Anaplasmataceae) in male Dermacentor andersoni (Acari: Ixodidae) transferred successively from infected to susceptible calves. J Med Entomol (1992) 1.24

Transstadial and intrastadial experimental transmission of Ehrlichia canis by male Rhipicephalus sanguineus. Vet Parasitol (2005) 1.24

The human ATP synthase beta subunit gene: sequence analysis, chromosome assignment, and differential expression. Genomics (1989) 1.24

Influenza A virus infection complicated by fatal myocarditis. Am J Forensic Med Pathol (2000) 1.23

Molecular aspects of virulence of Pasteurella haemolytica. Can J Vet Res (1990) 1.22

Human ehrlichiosis in Oklahoma. J Infect Dis (1989) 1.22

Ehrlichiosis in Belgium. Lancet (1995) 1.22

Seroepidemiology of infections due to spotted fever group rickettsiae and Ehrlichia species in military personnel exposed in areas of the United States where such infections are endemic. J Infect Dis (1995) 1.21

Modification of forearm resistance vessels by exercise training in young men. J Appl Physiol (1985) (1994) 1.21

Human ehrlichiosis. Mo Med (1989) 1.20

Simultaneous ehrlichiosis and Lyme disease. Pediatr Infect Dis J (1990) 1.20

Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient. AIDS (1999) 1.18

Temporal association of Amblyomma americanum with the presence of Ehrlichia chaffeensis reactive antibodies in white-tailed deer. J Wildl Dis (1995) 1.17

Bovine pneumonic pasteurellosis: immunity to Pasteurella haemolytica. J Am Vet Med Assoc (1988) 1.17

A human muscle adenine nucleotide translocator gene has four exons, is located on chromosome 4, and is differentially expressed. J Biol Chem (1989) 1.16

Detection of Ehrlichia canis in canine carrier blood and in individual experimentally infected ticks with a p30-based PCR assay. J Clin Microbiol (2002) 1.16

Human ehrlichiosis associated with cerebrospinal fluid pleocytosis: a case report. Am J Med (1989) 1.16

Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes (2006) 1.15

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53. Br J Cancer (2011) 1.15

Serum antibodies to antigens derived from a saline extract of Pasteurella haemolytica: correlation with resistance to experimental bovine pneumonic pasteurellosis. Vet Immunol Immunopathol (1985) 1.14

Extraction of capsular material from Pasteurella haemolytica. Am J Vet Res (1982) 1.14

Naturally occurring Ehrlichia chaffeensis infection in coyotes from Oklahoma. Emerg Infect Dis (2000) 1.13

Development and use of specific polymerase reaction for the detection of an organism resembling Ehrlichia sp. in white-tailed deer. J Wildl Dis (1997) 1.13

Persistent Ehrlichia chaffeensis infection in white-tailed deer. J Wildl Dis (2001) 1.12

Stroke in Devon: knowledge was good, but action was poor. J Neurol Neurosurg Psychiatry (2004) 1.12

Bovine pneumonic pasteurellosis: model for Pasteurella haemolytica- and Pasteurella multocida-induced pneumonia in cattle. Am J Vet Res (1984) 1.11

Bovine pneumonic pasteurellosis: effect of vaccination with live Pasteurella species. Am J Vet Res (1984) 1.11

Effect of prior natural exposure to Pasteurella haemolytica on resistance to experimental bovine pneumonic pasteurellosis. Am J Vet Res (1984) 1.10

Experience with a trigger tool for identifying adverse drug events among older adults in ambulatory primary care. Qual Saf Health Care (2009) 1.10

Anti-CD45RB/anti-TIM-1-induced tolerance requires regulatory B cells. Am J Transplant (2012) 1.10